SCHEMBL1305765

SCHEMBL1305765

CN(C)c1ccc(CNC(=O)C(=Cc2ccc(C(=O)O)cc2)COc2cccc3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ BLM P54132 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ ADAMTS5 Q9UNA0 1/20 0.43
▸ HPGD P15428 4/20 0.43
▸ CTDSP1 Q9GZU7 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ DAPK1 P53355 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ MRGPRX4 Q96LA9 1/20 0.41
▸ GAA P10253 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305762 1.00 MEN1 (0.45) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL27784529 0.92 LMNA (0.48) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL27784527 0.92 LMNA (0.48) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL1306509 0.92 KMT2A (0.43) MEN1KMT2AMAPK1MAPTSMN1; SMN2
SCHEMBL1305856 0.91 HDAC6 (0.47) MEN1KMT2AMAPK1MAPTHPGD
SCHEMBL1305858 0.91 HDAC6 (0.47) MEN1KMT2AMAPK1MAPTHPGD
SCHEMBL1306510 0.89 TRPM4 (0.41) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL1306720 0.88 MAPT (0.53) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL1306717 0.88 MAPT (0.53) MEN1KMT2AMAPK1POLBMAPT
SCHEMBL1307250 0.81 LMNA (0.52) MEN1KMT2AMAPK1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2913322-A2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same Korea Research Institute Of Chemical Technology (KR) 2015-09-02 — — EP disclosed
US-8053435-B2 Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-11-08 — — US disclosed
US-20100069630-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069630-A1 NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC1, HDAC3, HDAC11 MEN1 4379/4885KMT2A 111/4885MAPK1 2724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback